FDA has approved the first gene therapy drug for spinal muscular atrophy for children over 2 years of age
For citations:
FDA has approved the first gene therapy drug for spinal muscular atrophy for children over 2 years of age. Pediatric pharmacology. 2025;22(5):632. (In Russ.)
Views:
31
Email this article 